15-40471261-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_130468.4(CHST14):c.48G>T(p.Glu16Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000203 in 1,475,360 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E16K) has been classified as Uncertain significance.
Frequency
Consequence
NM_130468.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CHST14 | NM_130468.4 | c.48G>T | p.Glu16Asp | missense_variant | 1/1 | ENST00000306243.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CHST14 | ENST00000306243.7 | c.48G>T | p.Glu16Asp | missense_variant | 1/1 | NM_130468.4 | P1 | ||
CHST14 | ENST00000559991.1 | c.48G>T | p.Glu16Asp | missense_variant | 1/2 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151976Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000255 AC: 2AN: 78506Hom.: 0 AF XY: 0.0000221 AC XY: 1AN XY: 45344
GnomAD4 exome AF: 0.00000151 AC: 2AN: 1323384Hom.: 0 Cov.: 32 AF XY: 0.00000307 AC XY: 2AN XY: 652410
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151976Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74228
ClinVar
Submissions by phenotype
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 15, 2024 | The c.48G>T (p.E16D) alteration is located in exon 1 (coding exon 1) of the CHST14 gene. This alteration results from a G to T substitution at nucleotide position 48, causing the glutamic acid (E) at amino acid position 16 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at